106 related articles for article (PubMed ID: 38654015)
21. A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy.
Li JKM; Wang LL; Wong CYP; Chiu PKF; Teoh JYC; Kwok HSW; Leung SCH; Wong SH; Tsui SKW; Ng CF
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1063-1072. PubMed ID: 33850270
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial and Anti-Biofilm Activity of Omega-3 Polyunsaturated Fatty Acids against Periprosthetic Joint Infections-Isolated Multi-Drug Resistant Strains.
Coraça-Huber DC; Steixner S; Wurm A; Nogler M
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33810261
[No Abstract] [Full Text] [Related]
23. Gastrointestinal biofilms in health and disease.
Motta JP; Wallace JL; Buret AG; Deraison C; Vergnolle N
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):314-334. PubMed ID: 33510461
[TBL] [Abstract][Full Text] [Related]
24. The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial.
Vijay A; Astbury S; Le Roy C; Spector TD; Valdes AM
Gut Microbes; 2021; 13(1):1-11. PubMed ID: 33382352
[TBL] [Abstract][Full Text] [Related]
25. The role of the microbiota in human genetic adaptation.
Suzuki TA; Ley RE
Science; 2020 Dec; 370(6521):. PubMed ID: 33273073
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity.
Gevariya N; Lachance G; Robitaille K; Joly Beauparlant C; Beaudoin L; Fournier É; Fradet Y; Droit A; Julien P; Marette A; Bergeron A; Fradet V
Mol Cancer Res; 2021 Mar; 19(3):516-527. PubMed ID: 33262291
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health.
Fassarella M; Blaak EE; Penders J; Nauta A; Smidt H; Zoetendal EG
Gut; 2021 Mar; 70(3):595-605. PubMed ID: 33051190
[TBL] [Abstract][Full Text] [Related]
28. Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients.
Daisley BA; Chanyi RM; Abdur-Rashid K; Al KF; Gibbons S; Chmiel JA; Wilcox H; Reid G; Anderson A; Dewar M; Nair SM; Chin J; Burton JP
Nat Commun; 2020 Sep; 11(1):4822. PubMed ID: 32973149
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial Activity of EPA and DHA against Oral Pathogenic Bacteria Using an In Vitro Multi-Species Subgingival Biofilm Model.
Ribeiro-Vidal H; Sánchez MC; Alonso-Español A; Figuero E; Ciudad MJ; Collado L; Herrera D; Sanz M
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32937742
[TBL] [Abstract][Full Text] [Related]
30. Circulation of gut-preactivated naïve CD8
Akrami M; Menzies R; Chamoto K; Miyajima M; Suzuki R; Sato H; Nishii A; Tomura M; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23674-23683. PubMed ID: 32907933
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota in human metabolic health and disease.
Fan Y; Pedersen O
Nat Rev Microbiol; 2021 Jan; 19(1):55-71. PubMed ID: 32887946
[TBL] [Abstract][Full Text] [Related]
32. Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity.
Anhê FF; Jensen BAH; Varin TV; Servant F; Van Blerk S; Richard D; Marceau S; Surette M; Biertho L; Lelouvier B; Schertzer JD; Tchernof A; Marette A
Nat Metab; 2020 Mar; 2(3):233-242. PubMed ID: 32694777
[TBL] [Abstract][Full Text] [Related]
33. Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress.
Nyquist MD; Corella A; Coleman I; De Sarkar N; Kaipainen A; Ha G; Gulati R; Ang L; Chatterjee P; Lucas J; Pritchard C; Risbridger G; Isaacs J; Montgomery B; Morrissey C; Corey E; Nelson PS
Cell Rep; 2020 May; 31(8):107669. PubMed ID: 32460015
[TBL] [Abstract][Full Text] [Related]
34.
Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
[TBL] [Abstract][Full Text] [Related]
35. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
Coutzac C; Jouniaux JM; Paci A; Schmidt J; Mallardo D; Seck A; Asvatourian V; Cassard L; Saulnier P; Lacroix L; Woerther PL; Vozy A; Naigeon M; Nebot-Bral L; Desbois M; Simeone E; Mateus C; Boselli L; Grivel J; Soularue E; Lepage P; Carbonnel F; Ascierto PA; Robert C; Chaput N
Nat Commun; 2020 May; 11(1):2168. PubMed ID: 32358520
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Hofman MS; Lawrentschuk N; Francis RJ; Tang C; Vela I; Thomas P; Rutherford N; Martin JM; Frydenberg M; Shakher R; Wong LM; Taubman K; Ting Lee S; Hsiao E; Roach P; Nottage M; Kirkwood I; Hayne D; Link E; Marusic P; Matera A; Herschtal A; Iravani A; Hicks RJ; Williams S; Murphy DG;
Lancet; 2020 Apr; 395(10231):1208-1216. PubMed ID: 32209449
[TBL] [Abstract][Full Text] [Related]
37. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data.
Chong J; Liu P; Zhou G; Xia J
Nat Protoc; 2020 Mar; 15(3):799-821. PubMed ID: 31942082
[TBL] [Abstract][Full Text] [Related]
38. The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions.
Clinton SK; Giovannucci EL; Hursting SD
J Nutr; 2020 Apr; 150(4):663-671. PubMed ID: 31758189
[TBL] [Abstract][Full Text] [Related]
39. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program.
Labbé DP; Zadra G; Yang M; Reyes JM; Lin CY; Cacciatore S; Ebot EM; Creech AL; Giunchi F; Fiorentino M; Elfandy H; Syamala S; Karoly ED; Alshalalfa M; Erho N; Ross A; Schaeffer EM; Gibb EA; Takhar M; Den RB; Lehrer J; Karnes RJ; Freedland SJ; Davicioni E; Spratt DE; Ellis L; Jaffe JD; DʼAmico AV; Kantoff PW; Bradner JE; Mucci LA; Chavarro JE; Loda M; Brown M
Nat Commun; 2019 Sep; 10(1):4358. PubMed ID: 31554818
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids.
Miyamoto J; Igarashi M; Watanabe K; Karaki SI; Mukouyama H; Kishino S; Li X; Ichimura A; Irie J; Sugimoto Y; Mizutani T; Sugawara T; Miki T; Ogawa J; Drucker DJ; Arita M; Itoh H; Kimura I
Nat Commun; 2019 Sep; 10(1):4007. PubMed ID: 31488836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
